TAKEDA PHARMACEUTICAL COMPANY LIMITED Osaka, Japan, June 29, 2016 --- Takeda Pharmaceutical Company Limited today announced new assignment of Directors. The details are as follows;
- 1.New assignment of Non-Audit and Supervisory Committee Directors effective June 29, 2016;
| Name | Category | Role |
| Yasuchika Hasegawa | Existing | Director, Chairman of the Board |
| Christophe Weber | Existing | Representative Director, President & Chief Executive Officer |
| Shinji Honda | Existing | Director, Corporate Strategy Officer |
| Masato Iwasaki | Existing | Director, President, Japan Pharma Business Unit |
| Andrew Plump | Existing | Director, Chief Medical & Scientific Officer |
| Yoshiaki Fujimori | New | Outside Director |
| Emiko Higashi | New | Outside Director |
| Michel Orsinger | New | Outside Director |
| Masahiro Sakane | Existing | Outside Director |
| Toshiyuki Shiga | New | Outside Director |
| Fumio Sudo | Existing | Outside Director |
- 2.New assignment of Audit and Supervisory Committee Directors effective June 29, 2016;
| Name | Category | Role |
| Yasuhiko Yamanaka | New | Director, Audit & Supervisory Committee member |
| Shiro Kuniya | New | Outside Director, Chairperson of Audit & Supervisory Committee |
| Jean-Luc Butel | New | Outside Director, Audit & Supervisory Committee member |
| Koji Hatsukawa | New | Outside Director, Audit & Supervisory Committee member |
Takeda Pharmaceutical Co. Ltd. published this content on 29 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 June 2016 00:55:01 UTC.
Original documenthttp://www.takeda.com/news/2016/20160629_7473.html
Public permalinkhttp://www.publicnow.com/view/B3B5A5B578E0CC7C985022273CDB667AA09EBE9E
